• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青光眼的流行病学——一种与年龄相关的疾病。

The Epidemiology of Glaucoma - an Age-Related Disease.

机构信息

Augenklinik, Universitätsklinikum Hamburg-Eppendorf, Deutschland.

出版信息

Klin Monbl Augenheilkd. 2024 Feb;241(2):154-161. doi: 10.1055/a-2257-6940. Epub 2024 Feb 27.

DOI:10.1055/a-2257-6940
PMID:38412979
Abstract

BACKGROUND

Epidemiological studies describe the distribution of glaucoma and its risk factors in the general population.

MATERIAL AND METHODS

Epidemiological findings from population-based studies were extrapolated for the situation in Germany, in order to estimate current and future prevalence of glaucoma by using official population statistics for Germany.

RESULTS

The prevalence of glaucoma in the adult population above 40 years of age is currently 2.1%, resulting in 980 thousand subjects with glaucoma, plus at least one more million subjects with ocular hypertension (OHT). Two thirds of all glaucoma cases are above 70 years of age. By 2060, the prevalence of glaucoma will increase to 2.8%, due to the aging of the population.

CONCLUSIONS

Despite a decrease in the population size, glaucoma will become more prevalent in the future.

摘要

背景

流行病学研究描述了青光眼及其在普通人群中的危险因素的分布情况。

材料与方法

从基于人群的研究中推断出流行病学发现,以便利用德国官方人口统计数据来估计当前和未来的青光眼患病率。

结果

目前,40 岁以上成年人的青光眼患病率为 2.1%,这意味着有 98 万青光眼患者,加上至少还有 100 万患有眼压升高(OHT)的患者。所有青光眼病例中有三分之二的患者年龄在 70 岁以上。到 2060 年,由于人口老龄化,青光眼的患病率将上升至 2.8%。

结论

尽管人口规模有所下降,但未来青光眼的患病率将会增加。

相似文献

1
The Epidemiology of Glaucoma - an Age-Related Disease.青光眼的流行病学——一种与年龄相关的疾病。
Klin Monbl Augenheilkd. 2024 Feb;241(2):154-161. doi: 10.1055/a-2257-6940. Epub 2024 Feb 27.
2
Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion.与视网膜中央静脉阻塞和半侧视网膜中央静脉阻塞相关的眼压异常。
Ophthalmology. 2004 Jan;111(1):133-41. doi: 10.1016/j.ophtha.2003.03.002.
3
Prevalence of ocular hypertension and glaucoma in patients with chronic ocular graft-versus-host disease.慢性眼部移植物抗宿主病患者中高眼压症和青光眼的患病率
Graefes Arch Clin Exp Ophthalmol. 2016 May;254(5):923-8. doi: 10.1007/s00417-016-3312-3. Epub 2016 Mar 12.
4
Glaucoma and ocular hypertension in pediatric patients with cataracts.患有白内障的儿科患者中的青光眼和高眼压症。
J AAPOS. 1997 Jun;1(2):98-101. doi: 10.1016/s1091-8531(97)90006-9.
5
The projected increase in glaucoma due to the aging population in Austria from 2001 to 2031: results based on data of the Salzburg-Moorfields Collaborative Glaucoma Study.2001年至2031年奥地利因人口老龄化导致青光眼预计增加情况:基于萨尔茨堡-摩尔菲尔德青光眼协作研究数据的结果
Eur J Ophthalmol. 2007 Jan-Feb;17(1):45-52. doi: 10.1177/112067210701700107.
6
Vascular risk factors for primary open angle glaucoma: the Egna-Neumarkt Study.原发性开角型青光眼的血管危险因素:埃格纳-新马尔克特研究
Ophthalmology. 2000 Jul;107(7):1287-93. doi: 10.1016/s0161-6420(00)00138-x.
7
Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease.Vogt-Koyanagi-Harada 病患者的眼压升高或青光眼的患病率、风险因素和管理。
Br J Ophthalmol. 2021 Dec;105(12):1678-1682. doi: 10.1136/bjophthalmol-2020-316323. Epub 2020 Oct 3.
8
[Epidemiological and clinical features of primary open angle glaucoma in Bejaia: "The Bejaia Eye Study"].贝贾亚原发性开角型青光眼的流行病学和临床特征:“贝贾亚眼病研究”
J Fr Ophtalmol. 2023 Dec;46(10):1182-1194. doi: 10.1016/j.jfo.2023.05.027. Epub 2023 Oct 21.
9
[Prevalance of open angle glaucoma and ocular hypertension as a risk factor for primary open angle glaucoma in Wroclaw population. Wroclaw Epidemiology Study].[弗罗茨瓦夫人群中开角型青光眼和高眼压症作为原发性开角型青光眼危险因素的患病率。弗罗茨瓦夫流行病学研究]
Klin Oczna. 2004;106(1-2 Suppl):147-52.
10
Prevalence of open-angle glaucoma, glaucoma suspect, and ocular hypertension in thyroid-related immune orbitopathy.甲状腺相关免疫性眼眶病中开角型青光眼、青光眼可疑病例及高眼压症的患病率。
J Glaucoma. 2007 Jun-Jul;16(4):358-62. doi: 10.1097/IJG.0b013e31802e644b.

引用本文的文献

1
Understanding Glaucoma: Why it Remains a Leading Cause of Blindness Worldwide.了解青光眼:为何它仍是全球失明的主要原因。
Klin Monbl Augenheilkd. 2025 Jul;242(7):712-717. doi: 10.1055/a-2617-1575. Epub 2025 Jul 24.
2
Safety of lifitegrast: A real-world pharmacovigilance study based on FAERS.lifitegrast的安全性:一项基于FAERS的真实世界药物警戒研究。
PLoS One. 2025 Apr 24;20(4):e0321307. doi: 10.1371/journal.pone.0321307. eCollection 2025.
3
Changes in the Protein Composition of the Aqueous Humor in Patients with Glaucoma: An Update Review.
青光眼患者房水蛋白质组成的变化:最新综述
Int J Mol Sci. 2025 Mar 28;26(7):3129. doi: 10.3390/ijms26073129.